"This is a time to be excited for the future," said SalmoGen's new General Manager, Nick King, after his appointment.
Photo: Nick King LinkedIn profile.
Created to offer a high-quality supply of Atlantic salmon eggs from an American strain sourced from USDA as a strategic genetics partner, SalmoGen is a collaborative American broodstock undertaking between investors, strategic partners, academia, and government resources. Founded in late 2022, it was officially launched in March 2024 and it now announces the appointment of Nick King as its new General Manager.
According to the company's announcement, he comes with a strong technical and management background from well-known companies in the aquaculture industry such as Skretting, Benchmark, and, in recent years, Nordic Aquafarms. SalmoGen also highlights that Nick King's broad experience encompasses hatchery training, fish nutrition, farm permitting, and fish health.
In his new position, he will oversee day-to-day operations and development activities. The company says he is a welcome addition as SalmoGen is increasing its focus on broodstock development, production-related matters, and expansion of operations.
The design phase of the company's facility is coming to an end this summer and it will soon move forward with construction and expansion of operations. The company’s broodstock cohorts are currently held in leased facilities at the University of Maine where, in partnership with the USDA, it is developing the St. Johns Maine Strain.
As said above, SalmoGen is the result of a coalition of industry players, academic resources, and well-known investors, and that is precisely what the new General Manager of the company has highlighted in his statements upon his arrival to the position.
"SalmoGen brings together an incredible supporting cast of collaborators. I plan to continue the path established by the board so that SalmoGen may reach its full potential in the coming years," said Nick King.
On a more personal note, when sharing the news of his appointment on his LinkedIn profile, SalmoGen's new General Manager praised the people he has met and the professional relationships he has established throughout his career, which, he says, have helped him to get to this point. "This is a time to be excited for the future," he concluded.
SalmoGen was founded on a mission to establish a U.S. commercial egg supplier to enable industry long-term growth in the U.S. regulatory and risk environment. In the first development phase, its goal is to develop a capacity of 25 million eggs annually. Eggs of U.S. origin, from an Atlantic salmon strain from Maine, which will be destined for both domestic and international sales.
The company is the result of an investment partnership between Walton-backed investment firms Cuna Del Mar and Builders Vision, the Penobscot Indian Nation, and Xcelerate Aqua, and is also financially supported by the Finance Authority of Maine (FAME).
